SCHEMBL5536756

SCHEMBL5536756

COC(=O)c1ccccc1COC=O

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
LMNA P02545 2/20 0.55
KMT2A Q03164 1/20 0.50
TSHR P16473 1/20 0.49
HSD17B10 Q99714 4/20 0.47
CFTR P13569 1/20 0.47
HTT P42858 3/20 0.47
HIF1A Q16665 1/20 0.47
KDM4E B2RXH2 3/20 0.46
POLB P06746 2/20 0.46
ATM Q13315 1/20 0.46
GAA P10253 1/20 0.45
MAPK8 P45983 1/20 0.45
MAPK9 P45984 1/20 0.45
MAPK10 P53779 1/20 0.45
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GLA P06280 1/20 0.44
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5538272 0.84 ALDH1A1 (0.60) ALDH1A1LMNAKMT2ATSHRHSD17B10
SCHEMBL5545592 0.84 TSHR (0.61) ALDH1A1LMNATSHRHSD17B10HTT
SCHEMBL6669086 0.82 ALDH1A1 (0.62) ALDH1A1LMNAKMT2ATSHRHSD17B10
SCHEMBL3150175 0.82 ALDH1A1 (0.62) ALDH1A1LMNAKMT2ATSHRHSD17B10
SCHEMBL11346736 0.81 TP53 (0.53) ALDH1A1KMT2ATSHRHSD17B10HTT
SCHEMBL9741184 0.80 CTSD (0.47) ALDH1A1LMNAKMT2AGAAHPGD
SCHEMBL10261769 0.80 SRC (0.39) ALDH1A1LMNAKMT2ATSHRHTT
SCHEMBL19929637 0.80 ALDH1A1 (0.43) ALDH1A1LMNAKMT2ATSHRHSD17B10
SCHEMBL19929648 0.80 MRGPRX4 (0.45) ALDH1A1LMNAKMT2ATSHRHSD17B10
SCHEMBL27522004 0.80 ALDH1A1 (0.59) ALDH1A1LMNAKMT2ATSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 US disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed
EP-1004621-B1 GAMMA-RAY STABILIZER AND THERMOPLASTIC POLYMER COMPOSITION CONTAINING THE SAME TEIJIN CHEMICALS LTD (JP) 2004-09-15 EP disclosed
US-6485657-B1 Gamma-ray stabilizer and thermoplastic polymer compound including the said stabilizer TEIJIN, LIMITED (JP) 2002-11-26 US disclosed
EP-1004621-A1 GAMMA-RAY STABILIZER AND THERMOPLASTIC POLYMER COMPOSITION CONTAINING THE SAME TEIJIN LIMITED (JP) 2000-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 ALDH1A1 355/4885LMNA 4152/4885KMT2A 4267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.